From Yahoo Finance: 2025-05-13 08:00:00

Intelligent Bio Solutions Inc. reported a third-quarter 2025 loss of 44 cents per share, down from $1.43 a year ago. Sales decreased to $728.87 thousand from $823.80 thousand. Total revenues increased by 20% quarter-over-quarter due to expansion and customer acquisition.

The company secured 35 new accounts, bringing the total active account base to over 450. Cartridge revenue increased from 49% to 58%, and total cash and cash equivalents were $2.81 million. Gross profits for the fiscal third quarter were $341,368, a 91% increase year-over-year.

Intelligent Bio Solutions received a U.S. patent for its Fingerprinting Drug Screening Cartridge, strengthening its proprietary technology protection. As the company continues to drive global growth, strategic initiatives and IP portfolio protection support long-term commercial success.

INBS stock was up 4.92% at $1.28 during the premarket session. The company’s fiscal third-quarter gross profit increased by 91%. For more trade ideas and stock analysis, visit Benzinga.com.

Read more: Intelligent Bio Solutions Q3 Gross Profit Jumps By 91%